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Despite the major advances in thoracic aortic surgery with
DHCA, there are still major clinical challenges, including this
thrombotic syndrome in the face of standard-of-care anticoagula-
tion. Further collaborative research should advance our under-
standing and management of this thrombotic syndrome in the
future.
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An innovative technique for the relief of right ventricular trabecular
cavity obliteration in endomyocardial fibrosis
Ana Olga Mocumbi, MD,a Daniel Sidi, MD, PhD,b Pascal Vouhe, MD, PhD,a and Magdi Yacoub, FRS,a London, United
Kingdom, Maputo, Mozambique, and Paris, France
Endomyocardial fibrosis (EMF) mainly affects personsfrom Africa, South America, and Asia.1 The pathogen-esis of this condition remains unknown. In advancedforms, EMF produces marked disability and carries a
poor prognosis. Although there is consensus about the potential
value of surgical intervention in symptomatic patients, there is still
debate regarding the exact timing and the surgical technique to be
used.2,3
EMF is characterized by endocardial fibrosis affecting the
inflow tract and the apex of 1 or both ventricles, commonly
involving the atrioventricular valves. The right ventricle is affected
in most cases.4 In severe forms, marked reduction of ventricular
volume is thought to be due to the presence of a plug of fibrous
tissue involving both the trabecular part and the apex.5
We here describe a new mechanism for apical obliteration of
the right ventricle in EMF. The concept was used to evolve and
apply a new surgical technique to increase ventricular volume,
improve contractile function by releasing the myocardium and
making use of viable myocardium in the obliterated area, and
correct the tricuspid regurgitation.
This technique was conceived after detailed echocardiographic
examination showed a layer of endocardial fibrosis forming an
artificial floor to the right ventricle and isolating the trabecular part
from the rest of the ventricular cavity (Figure 1, A).
After establishing cardiopulmonary bypass with moderate hy-
pothermia, cold blood antegrade cardioplegia was used for myo-
cardial protection. A wide longitudinal right atriotomy was per-
formed to expose the tricuspid valve, which was usually markedly
dilated, allowing wide access to the right ventricle. The distribu-
tion and extent of pathologic involvement of the tricuspid valve
apparatus and right ventricular cavity were carefully defined.
In patients with obliteration of the trabecular part of the right
ventricle described in this article, white glistering fibrous tissue 2
to 3 mm in thickness was found lining the inflow tract and
extended down into the cavity of the right ventricle to the level of
the junction of the inflow and trabecular parts. The fibrotic process
produced a relatively thin layer that formed an “artificial floor” to
the right ventricle, separating the inflow cavity from the obliterated
muscular trabecular part. The fibrotic process spared the tricuspid
leaflets and chordae.
Endocardial resection was started near the tricuspid annulus by
retracting the leaflets of the valve. If the latter was fused in some
areas, it was mobilized if at all possible. After the development of
a cleavage plane by means of sharp dissection, a combination of
sharp and blunt dissection was used to excise the thick, fibrous
endocardial lining. This process was continued into the ventricular
cavity, ensuring preservation and mobilization of the tricuspid
valve chordae and papillary muscles. The membrane covering the
entry into the trabecular part was removed (Figure 1, B), exposing
the fused muscular tissue underneath it. This was followed by
recreating a cavity inside the trabecular part by mainly separating
the fused trabeculae but, if necessary, also excising some muscular
tissue, taking care not to perforate the ventricular wall.
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In patients with complete fusion of the leaflets and chordae to
the mural fibrosis, freeing of the tricuspid valve apparatus was
performed. Reconstruction of the tricuspid valve with 2 bands of
polytetrafluroethylene* tubes was used in all patients.
Clinical Summary
Between February 2003 and June 2006, 4 patients with right
ventricular trabecular cavity obliteration were treated by means of
this operation. The clinical characterization of these patients and
the procedures used are summarized in Table 1. There was no early
or late mortality. Pericardial tamponade occurred in 2 patients.
Patients were kept on low doses of diuretics, aspirin, and angio-
tensin-converting enzyme inhibitors for 6 months. At a mean
follow-up of 18 months (range, 9–48 months), all patients are
asymptomatic. A two-dimensional echocardiogram showed an in-
crease in right ventricular cavity dimensions to nearly normal
levels with improvement in systolic function, acceptable compli-
ance in all, and mild tricuspid regurgitation in 1 patient. Magnetic
resonance imaging analysis in 1 patient confirmed these results.
Discussion
A new mechanism for right ventricular trabecular cavity oblitera-
tion in EMF is described. A surgical technique for its relief was
developed and used with very encouraging results in terms of
restoration of both structural and functional changes of the right
ventricle. There was no evidence of recurrence over the relatively
short follow-up period. We hope that familiarity with this tech-
nique will help to stimulate early diagnosis and timely treatment of
EMF before shrinkage of the right ventricle occurs and thus have
a favorable effect on the prognosis of this potentially fatal disease.
We thank the Magdi Yacoub Institute and the Chain of
Hope–UK for their financial support of surgical missions to
Mozambique and Drs Beatriz Ferreira and Gavin Wright for their
help.
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Table 1. Clinical and preoperative data of the 4 patients operated on with the technique
Patient no. Age (y) Sex NYHA class Diagnosis
Associated
procedures CPB (min) AXC (min)
Hospital
stay (d)
1 14 F III REMF TR 93 65 6
2 11 M III BEMF TR, MR, LVE 124 84 10
3 9 F IV BEMF TR, MR 92 61 7
4 8 M III REMF TR 66 0 9
No aortic clamping was used in patient 4, who had undergone a previous Glenn procedure. NYHA, New York Heart Association; CPB, cardiopulmonary
bypass; AXC, aortic crossclamp; F, female; REMF, right-sided endomyocardial fibrosis; TR, tricuspid repair; M, male; BEMF, bilateral endomyocardial
fibrosis; MR, mitral repair; LVE, left ventricular endocardial resection.
Figure 1. A, Echocardiogram showing obliteration of the trabecular part of the right ventricle in a case of bilateral
endomyocardial fibrosis. Notice fibrosis in the apex of the left ventricle and dilatation of both atria. B, Through
sharp dissection, a plane of cleavage is created, allowing the separation of the fibrous tissue from the myocardium.
Excision of the fibrotic tissue is done as a block, revealing a healthy myocardium underneath it.
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A novel technique of utilizing artificial chordae
for repair of mitral valve prolapse
Marcio Scorsin, MD, PhD,a Nawwar Al-Attar, FRCS, PhD,b and
Arrigo Lessana, MD,c Turin, Italy, Paris, France, and St Denis, France
Mitral valve repair provides excellent long-term re-sults and superior survival compared with those ofvalve replacement in the management of mitralregurgitation and should be considered whenever
possible.1 Despite the existence of a variety of standardized tech-
niques of surgical repair, it is performed in only one half of the
cases.2 Technically, repair of posterior leaflet prolapse (PLP) is
less complex, with excellent long-term results, compared with
those of anterior leaflet prolapse (ALP) or bileaflet prolapse. In
either case, the feasibility and durability of mitral valve repair
remain highly dependent on surgical experience.3
We propose a new approach to extend repair techniques to
extensive and complex valve prolapse. From September 2006 to
February 2007, 9 patients with severe mitral regurgitation caused
by severe ALP or PLP underwent valve repair with an artificial
chordae system device. Preoperative cardiac magnetic resonance
imaging and/or perioperative transesophageal echocardiography
determined the ideal chordae length required to manufacture the
device, which was constructed perioperatively.
Clinical Summary
During chest opening and cardiopulmonary bypass installation, the
chordae system is manufactured according to preoperative mea-
surements. The device is composed of 2 sets of 4 artificial chordae
(4-mm polytetrafluoroethylene sutures; Gore Tex, WL Gore &
Associates, Flagstaff, Ariz) attached to a 3-mm strip of knitted
polyester (Bard Sau-
vage, Tempe, Ariz) 18
mm wide, leaving 4
mm between each chorda (simulating the edge of the cusp). In the
other extremity, 1 single point is fused and from that 2 stitches
arise with 2 needles at the extremity (Figure 1).
The device is applied by suturing the strip to the free edge of
the prolapsed leaflet by continuous suture. Each array is anchored
to the tip of the correspondent papillary muscle by only 1 stitch.
Systolic stress is therefore evenly distributed over both papillary
muscles and across the free mitral edge. Two lengths (22 and 25
mm) of the chordae system were used in our series to repair ALP
in 6 patients and PLP in 3 patients. A prosthetic annuloplasty ring
was inserted in all patients. Nine-month follow-up echocardio-
grams showed no mitral regurgitation in 7 patients and mild mitral
regurgitation in 2 patients.
Discussion
Correction of mitral insufficiency from PLP is frequently feasible
with established repair techniques. On the other hand, repair of
ALP is associated with a higher risk of reoperation, and with
bileaflet prolapse the success rate of achieving repair has been
reported to be as low as 40%, with some authors advising in such
cases to replace the valve directly.3
From the Unita Operativa di Cardiochirurgia, Villa Maria Pia Hospital,a
Turin, Italy; Service de Chirurgie Cardiaque, Hôpital Bichat,b Paris, France;
and Centre Cardiologique du Nord,c St Denis, France.
Received for publication May 6, 2007; accepted for publication June 1,
2007.
Address for reprints: Marcio Scorsin, MD, PhD, Villa Maria Pia Hospital,
Strada Mongreno, 180, 10132 Turin Italy (E-mail: mscorsin@hotmail.com).
Arrigo Lessana is co-owner with Dr Scorsin of a patent on the device
described in this report.
J Thorac Cardiovasc Surg 2007;134:1072-3
0022-5223/$32.00
Copyright © 2007 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.06.012
Drs Scorsin, Lessana, and Al-Attar (left to right)
Figure 1. The device reproduces the chordae system. The number
of chordae and their length can be adapted to surgical needs.
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